CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $40,000 | -53.5% | 1,199 | -67.4% | 0.00% | – |
| Q1 2021 | $86,000 | -88.9% | 3,677 | -86.3% | 0.00% | – |
| Q4 2020 | $772,000 | -26.1% | 26,815 | -48.0% | 0.00% | – |
| Q3 2020 | $1,044,000 | -39.7% | 51,542 | -10.6% | 0.00% | -100.0% |
| Q2 2020 | $1,731,000 | +423.0% | 57,632 | +446.0% | 0.00% | – |
| Q1 2020 | $331,000 | -0.9% | 10,555 | +49.0% | 0.00% | – |
| Q4 2019 | $334,000 | +79.6% | 7,083 | -75.4% | 0.00% | – |
| Q3 2019 | $186,000 | +8.8% | 28,832 | +106.9% | 0.00% | – |
| Q2 2019 | $171,000 | +28.6% | 13,937 | +42.1% | 0.00% | – |
| Q1 2019 | $133,000 | +6550.0% | 9,805 | +1507.4% | 0.00% | – |
| Q4 2018 | $2,000 | -50.0% | 610 | +6.8% | 0.00% | – |
| Q3 2018 | $4,000 | – | 571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |